Perritt Capital Management Inc Johnson & Johnson Transaction History

Perritt Capital Management Inc

$185 Million
Q3 2024

A detailed history of Perritt Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Perritt Capital Management Inc holds 3,850 shares of JNJ stock, worth $589,974. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,850

Previous 3,871 0.54%

Holding current value

$589,974

Previous $565,000 10.27%

% of portfolio

0.34%

Previous 0.33%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $3,055 - $3,514	-21 Reduced 0.54%	3,850 $623,000
Q2 2024 Aug 07, 2024	BUY	$144.38 - $157.78 $25,122 - $27,453	174 Added 4.71%	3,871 $565,000
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $1,707 - $1,790	11 Added 0.3%	3,697 $584,000
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $49,358 - $53,860	-339 Reduced 8.42%	3,686 $577,000
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $47,694 - $51,327	-309 Reduced 7.13%	4,025 $666,000
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $15,105 - $18,026	-100 Reduced 2.26%	4,334 $671,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $6,888 - $7,730	-43 Reduced 0.96%	4,434 $783,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $12,745 - $14,182	-79 Reduced 1.73%	4,477 $731,000
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $13,455 - $14,880	80 Added 1.79%	4,556 $809,000
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $158 - $179	-1 Reduced 0.02%	4,476 $793,000
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $5,301 - $5,882	34 Added 0.77%	4,477 $766,000
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $28,101 - $31,227	174 Added 4.08%	4,443 $718,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $3,827 - $4,105	24 Added 0.57%	4,269 $703,000
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $30,849 - $35,410	-225 Reduced 5.03%	4,245 $668,000
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $1,403 - $1,538	-10 Reduced 0.22%	4,470 $665,000
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $12,881 - $15,551	-100 Reduced 2.18%	4,480 $630,000
Q4 2019 Feb 05, 2020	SELL	$127.5 - $146.44 $3,060 - $3,514	-24 Reduced 0.52%	4,580 $668,000
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $7,997 - $8,954	-63 Reduced 1.35%	4,604 $596,000
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $8,262 - $9,087	-63 Reduced 1.35%	4,604 $641,000
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $8,262 - $9,087	63 Added 1.37%	4,667 $652,000
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $1,131 - $1,258	-9 Reduced 0.19%	4,667 $652,000
Q4 2018 Feb 08, 2019	BUY	$122.84 - $147.84 $4,053 - $4,878	33 Added 0.71%	4,676 $603,000
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $1,626 - $1,925	-13 Reduced 0.28%	4,643 $591,000
Q4 2017 Jan 25, 2018	SELL	$131.22 - $143.62 $6,561 - $7,181	-50 Reduced 1.06%	4,656 $651,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $609,285 - $637,098	4,706	4,706 $612,000

Others Institutions Holding JNJ

# of Institutions

4,253

Shares Held

1.68B

Call Options Held

14M

Put Options Held

11.8M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $401B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Account

Perritt Capital Management Inc Johnson & Johnson Transaction History